Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
227.50
Ask:
228.50
Spread: 1.00 (0.44%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

4 Nov 2022 07:00

RNS Number : 2795F
Morgan Advanced Materials PLC
04 November 2022
 

 

Press Release

Morgan Advanced Materials plc

4 November 2022

Trading Update

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2022.

Current Trading

Sales for the nine months to September 2022 were 10.5% higher for the Group, on an organic constant-currency basis, compared with the same period last year.

By business unit, organic constant-currency sales performance for the nine months to September 2022, compared with the same period last year, were as follows:

Thermal Ceramics +10.7%

Molten Metal Systems +17.4%

Electrical Carbon +7.2%

Seals and Bearings +6.9%

Technical Ceramics +13.0%

Group +10.5%

Outlook

Our revenue growth has remained robust. Despite having seen the expected slight moderation of growth rates in our third quarter, reflecting challenges in the wider economy, we now expect our full year organic constant-currency growth to be in the range 7-9%, above our previous guidance. We expect adjusted operating profit for full year 2022 to be marginally above the top end of current analysts' forecasts.

Pete Raby, Chief Executive Officer, said:

"We are delivering robust revenue growth, despite the challenging environment, and improving profitability, with inflation continuing to be more than offset by pricing and continuous improvement activity".

Upcoming events

A capital markets event for institutional investors and analysts will be held on 6 December 2022 in London. Pete Raby and Richard Armitage will be joined by senior leaders from across the group for a series of presentations covering our strategic progress, faster growing market opportunities, ESG approach and the group's financial and M&A framework and aspirations. The slides will be available on the group's website.

The full year results are expected to be released on 28 February 2023.

For further enquiries:

Pete Raby Morgan Advanced Materials plc 01753 837000

Richard Armitage

Nina Coad Brunswick 0207 404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXLFBLFLBFBX
Date   Source Headline
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.